MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Quercetin hinders Glial Activation to Alleviate the Cadmium Induced Dopaminergic Alteration via TNFα mediated CAMKIIα/ERK activation

    R. Shukla, V. Khanna, R. Gupta (bahraich, India)

    Objective: The present study has therefore been carried out identify neuroprotective role of quercetin in alleviating the cadmium induced dopaminergic dysfunctions via glial mediated deactivation…
  • 2023 International Congress

    Spinocerebellar ataxia type 28 presenting as spastic paraparesis

    R. Hoe, S. Neo, L. Tan (Singapore, Singapore)

    Objective: To describe a patient with spinocerebellar ataxia type 28 (SCA28) presenting with isolated spastic paraparesis. Background: Autosomal dominant (AD) mutations in the ATPase family…
  • 2023 International Congress

    Efficacy and safety of adjunctive oral therapy in Parkinson’s disease with motor complications: a systematic review and network meta-analysis

    V. Sisodia, L. Dubbeld, RMA. de Bie, GS. Duarte, J. Costa, JM. Dijk (Amsterdam, Netherlands)

    Objective: To review the evidence and compare the efficacy and safety of catechol-O-methyltransferase inhibitors (COMT-Is), dopamine agonists (DAs) and monoamine-oxidase B inhibitors (MAOB-Is) as adjunctive…
  • 2023 International Congress

    Investigating factors contributing to clinical trial recruitment in Parkinson’s Disease within the Black community

    J. Adrissi, C. Onwumere, D. Dominguez, M. Lyleroehr, E. Gray, K. Williams, E. Zivin, D. Larson (Los Angeles, USA)

    Objective: This study aimed to investigate the facilitators and barriers to Parkinson’s disease (PD) research engagement within Black people with PD and Black healthy controls.…
  • 2023 International Congress

    Compliance with national and international guidelines in the treatment of non-motor symptoms in late stage Parkinson’s disease

    K. Rosqvist, P. Odin (Lund, Sweden)

    Objective: Against a background of the national and international Parkinson's disease (PD) treatment guidelines, the aim of this study was to investigate to which degree…
  • 2023 International Congress

    Is it safe to switch from constant voltage to constant current with a mixed Internal Pulse Generator in deep brain stimulation

    G. Ozturk Ozluk (Istanbul, Turkey)

    Objective: Deep brain stimulation (DBS) is an efficient treatment modality for Parkinson's Disease (PD), essential tremor and dystonia. Differing from the Constant Voltage-(CV)-DBS devices, Constant…
  • 2023 International Congress

    Does sex affect worsening of cognitive and IADL functions in PD with and without PD-MCI?

    I. Liepelt-Scarfone, M. Bode, S. Solbrig, K. Brockmann, W. Maetzler, I. Wurster, M. Timmers, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To define how sex affects worsening of cognition and instrumental activities of daily living (IADLs) in a heterogeneous cohort of people with Parkinson’s disease…
  • 2023 International Congress

    Telemedicine and in-person encounters in a Huntington’s disease cohort: virtually the same

    E. Girouard, JF. Daneault, A. James-Palmer, S. Chouinard, A. Richard (Montréal, Canada)

    Objective: The aim of this study was to assess the impact of virtual care provision modalities (VPM) on patient satisfaction (PS) metrics for the specialized…
  • 2023 International Congress

    GBA haplotypes and age at onset of Parkinson’s disease in the Asian population

    C. Li, R. Ou, Y. Hou, Q. Wei, L. Zhang, K. Liu, J. Lin, X. Chen, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the involvement of GBA haplotypes in age at onset of Parkinson's disease in the Asian population. Background: GBA is an important risk…
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley